Since rivaroxaban showed no antithrombotic activity superior to aspirin, the US Food and Drug Administration (FDA) approved it in combination with aspirin to reduce the risk of major cardiovascular (CV) events in adults with chronic coronary heart disease (CAD) peripheral artery disease (PAD).
By hook or by crook but rivaroxaban should be sold out. Truly aspirin is a magic wand.
Comfortable Monitors of Blood Pressure and Heart Rate at a low price for you
Smart gadgets with HRV function for your personal health’ control, science, and clinical practics